Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI)-Reference-Cited by-同舟云学术

Randomized placebo controlled trial evaluating the safety and efficacy of single low-dose intracoronary insulin-like growth factor following percutaneous coronary intervention in acute myocardial infarction (RESUS-AMI)

Published:2018-06 Issue: Volume:200 Page:110-117
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Caplice Noel M.,DeVoe Mary C.,Choi Janet,Dahly Darren,Murphy Theodore,Spitzer Ernest,Van Geuns Robert,Maher Michael M.,Tuite David,Kerins David M.,Ali Mohammed T.,Kalyar Imtiaz,Fahy Eoin F.,Khider Wisam,Kelly Peter,Kearney Peter P.,Curtin Ronan J.,O’Shea Conor,Vaughan Carl J.,Eustace Joseph A.,McFadden Eugene P.

Funder

Health Research Board of Ireland

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use;Miller;Circ Cardiovasc Qual Outcomes,2012

2. Cell therapy for cardiac repair—lessons from clinical trials;Behfar;Nat Rev Cardiol,2014

3. Time to give up on cardioprotection? A critical appraisal of clinical studies on ischemic pre-, post-, and remote conditioning;Heusch;Circ Res,2016

4. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I;Wang;Circ Res,1998

5. Potent long-term cardioprotective effects of single low-dose insulin-like growth factor-1 treatment postmyocardial infarction;O'Sullivan;Circ Cardiovasc Interv,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression analysis of insulin-like growth factor 1, neutrophil/lymphocyte ratio, and inflammatory factors in children with Mycoplasmal pneumonia;Materials Express;2023-12-01

2. Circulating IGF-1 and IGFBP-2 may be biomarkers for risk stratification in patients with acute coronary syndrome: A prospective cohort study;Nutrition, Metabolism and Cardiovascular Diseases;2023-09

3. Synergistic effects of hormones on structural and functional maturation of cardiomyocytes and implications for heart regeneration;Cellular and Molecular Life Sciences;2023-08

4. The impact of circulating IGF-1 and IGFBP-2 on cardiovascular prognosis in patients with acute coronary syndrome;Frontiers in Cardiovascular Medicine;2023-03-10

5. Biologics and cardiac disease: challenges and opportunities;Trends in Pharmacological Sciences;2022-11